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Abstract
Linear mixed models are a powerful statistical tool for identifying genetic associations and 
avoiding confounding. However, existing methods are computationally intractable in large 
cohorts, and may not optimize power. All existing methods require time cost O(MN2) (where N = 
#samples and M = #SNPs) and implicitly assume an infinitesimal genetic architecture in which 
effect sizes are normally distributed, which can limit power. Here, we present a far more efficient 
mixed model association method, BOLT-LMM, which requires only a small number of O(MN)-
time iterations and increases power by modeling more realistic, non-infinitesimal genetic 
architectures via a Bayesian mixture prior on marker effect sizes. We applied BOLT-LMM to nine 
quantitative traits in 23,294 samples from the Women’s Genome Health Study (WGHS) and 
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observed significant increases in power, consistent with simulations. Theory and simulations show 
that the boost in power increases with cohort size, making BOLT-LMM appealing for GWAS in 
large cohorts.
Linear mixed models are emerging as the method of choice for association testing in 
genome-wide association studies (GWAS) because they account for both population 
stratification and cryptic relatedness and achieve increased statistical power by jointly 
modeling all genotyped markers1–12. However, existing mixed model methods still have 
limitations. First, mixed model analysis is computationally expensive. Despite a series of 
recent algorithmic advances, current algorithms require either O(MN2) or O(M2N) total 
running time, where M is the number of markers and N is the sample size. This cost is 
becoming prohibitive for large cohorts, forcing existing methods to subsample the markers 
so that M<N (ref.5). Second, current mixed model methods fall short of achieving maximal 
statistical power owing to suboptimal modeling assumptions regarding the genetic 
architectures underlying phenotypes. The standard linear mixed model implicitly assumes 
that all variants are causal with small effect sizes drawn from independent Gaussian 
distributions—the “infinitesimal model”—whereas in reality, complex traits are estimated to 
have roughly a few thousand causal loci13,14.
Methodologically, efforts to more accurately model non-infinitesimal genetic architectures 
have followed two general thrusts. One approach is to apply the standard infinitesimal 
mixed model but adapt the input data. For example, large-effect loci can be explicitly 
identified and conditioned out as fixed effects7, or the mixed model can be applied to only a 
selected subset of markers9,11,15,16. A more flexible alternative approach is to adapt the 
mixed model itself by taking a Bayesian perspective and modeling SNP effects with non-
Gaussian prior distributions that better accommodate both small- and large-effect loci. Such 
methods were pioneered in livestock genetics to improve prediction of genetic values17 and 
have been extensively developed in the plant and animal breeding literature for the purpose 
of genomic selection18. These techniques are of interest in the association testing setting 
because models that improve prediction should in theory enable corresponding 
improvements in association power (via conditioning on other associated loci when testing a 
candidate marker9,12). Here, we present an algorithm that performs mixed model analysis in 
a small number of O(MN)-time iterations and increases power by modeling non-
infinitesimal genetic architectures. Our algorithm fits a Gaussian mixture model of SNP 
effects19, using a fast variational approximation20–22 to compute approximate phenotypic 
residuals, and tests the residuals for association with candidate markers via a retrospective 
score statistic23 that provides a bridge between Bayesian modeling for phenotype prediction 
and the frequentist association testing framework. We calibrate our statistic using an 
approach based on the recently developed LD Score regression technique24. The entire 
procedure operates directly on raw genotypes stored compactly in memory and does not 
require computing or storing a genetic relationship matrix. In the special case of the 
infinitesimal model, we achieve results equivalent to existing methods at dramatically 
reduced time and memory cost.
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We provide an efficient software implementation of our algorithm, BOLT-LMM, and 
demonstrate its computational efficiency on simulated data sets of up to 480,000 individuals. 
Our simulations also show that BOLT-LMM achieves increased association power over 
standard infinitesimal mixed model analysis of traits driven by a few thousand causal SNPs. 
We applied BOLT-LMM to perform mixed model analysis of nine quantitative traits in 
23,294 samples from the Women’s Genome Health Study (WGHS)25 and observed 
increased association power equivalent to up to 10% increase in effective sample size. We 
demonstrate through theory and simulations that the power boost increases with cohort size, 
making BOLT-LMM a promising approach for large-scale GWAS.
Results
Overview of Methods
The BOLT-LMM algorithm consists of four main steps, each of which require a small 
number of O(MN)-time iterations. These steps are: (1a) Estimate variance parameters; (1b) 
Compute infinitesimal mixed model association statistics (denoted BOLT-LMM-inf); (2a) 
Estimate Gaussian mixture parameters; (2b) Compute Gaussian mixture model association 
statistics (BOLT-LMM). Step 1a computes results nearly identical to standard variance 
components analysis but applies a stochastic approximation algorithm26,27 that reduces time 
and memory cost by circumventing spectral decomposition, which is expensive for large 
sample sizes. Instead, the approximation algorithm only requires solving linear systems of 
mixed model equations, which can be accomplished efficiently using conjugate gradient 
iteration28,29. Step 1b likewise circumvents spectral decomposition by introducing a new 
retrospective mixed model association statistic similar to GRAMMAR-Gamma10 and 
MASTOR23, which we compute—up to a calibration constant—using only solutions to 
linear systems of equations. We estimate the calibration constant by computing and 
comparing the new statistic and the standard prospective mixed model statistic at a random 
subset of SNPs, which can likewise be accomplished efficiently using conjugate gradient 
iteration. This procedure is similar in spirit to GRAMMAR-Gamma calibration but requires 
only O(MN)-time iterations.
Steps 2a and 2b are Gaussian mixture parallels of steps 1a and 1b. BOLT-LMM’s non-
infinitesimal model amounts to a generalization of the standard mixed model, which from a 
Bayesian perspective imposes a Gaussian prior distribution on SNP effect sizes. BOLT-
LMM relaxes this assumption by using a mixture of two Gaussians as the prior, giving the 
model greater flexibility to accommodate large-effect SNPs while maintaining effective 
modeling of genome-wide effects (e.g., ancestry). Exact posterior inference is no longer 
tractable under the generalized model, so BOLT-LMM instead computes a variational 
approximation20–22 that converges after a small number of O(MN)-time iterations. Step 2a 
applies this method within 5-fold cross-validation to estimate best-fit parameters for the 
prior distribution (taking into account variance parameters estimated in Step 1a) based on 
out-of-sample prediction accuracy. If the prediction accuracy of the best-fit Gaussian 
mixture model exceeds that of the infinitesimal model by at least a specified amount, Step 
2b is then run to compute association statistics by testing each SNP against the residual 
phenotype obtained from the Gaussian mixture model and calibrating the test statistics 
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against the results of Step 1b using LD Score regression24. Otherwise, the BOLT-LMM 
association statistic is the same as BOLT-LMM-inf. Both Step 1b and Step 2b are performed 
using a leave-one-chromosome-out (LOCO) scheme to avoid proximal contamination5,9,12. 
(The software also supports subdividing chromosomes into more segments; see Online 
Methods.) The key properties of BOLT-LMM regarding speed and modeling assumptions 
are compared to existing methods in Table 1.
Computational cost of BOLT-LMM versus existing methods
To analyze the computational performance of BOLT-LMM, we simulated data sets of sizes 
ranging from N=3,750 to 480,000 individuals and M=300,000 SNPs. We used genotypes 
from the WTCCC2 data set30 analyzed in ref.12, which contains 15,633 individuals of 
European ancestry, to form mosaic chromosomes, and we used a phenotype model in which 
5,000 SNPs explained 20% of phenotypic variance (Supplementary Note).
We benchmarked BOLT-LMM against existing mixed model association methods, running 
each method for up to 10 days on machines with 96GB of memory. BOLT-LMM completed 
all analyses through N=480,000 individuals within these constraints, whereas previous 
methods could only analyze a maximum of N=7,500–30,000 individuals (Fig. 1 and 
Supplementary Table 1). All previous methods require O(MN2) running time (for M>N), 
whereas the running time of BOLT-LMM scales roughly with MN1.5 (Fig. 1a and 
Supplementary Fig. 1a). We also observed substantial savings in memory use with BOLT-
LMM (Fig. 1b and Supplementary Fig. 1b), which requires little more than the MN/4 bytes 
of memory needed to store raw genotypes (as in GenABEL software31).
The running time of BOLT-LMM depends not only on the cost of matrix arithmetic, which 
scales linearly with M and N, but also the number of O(MN)-time iterations required for 
convergence, which empirically scales roughly as N0.5 (Supplementary Fig. 1) and also 
varies with heritability, relatedness, and population structure (Supplementary Note and 
Supplementary Fig. 2). These observations apply both to the full Gaussian mixture modeling 
performed by BOLT-LMM and to the subset of the computation (Steps 1a and 1b) needed to 
compute BOLT-LMM-inf infinitesimal mixed model association statistics, which in our 
benchmarks required ≈40% of the full BOLT-LMM run time (Fig. 1a and Supplementary 
Fig. 1a). Our results show that even on very large data sets, BOLT-LMM is efficient enough 
to enable mixed model analysis using a Gaussian mixture prior, which we recommend 
because of its potential to increase power.
Power and false positive control of BOLT-LMM in simulations
To assess the power of BOLT-LMM to detect associated loci, we performed additional 
simulations using real genotypes from the WTCCC2 data set, which is an ancestry-stratified 
sample containing both Northern and Southern European samples. We simulated phenotypes 
with 1,250–10,000 causal SNPs13,14 explaining 50% of phenotypic variance and an 
additional 60 standardized effect SNPs explaining 2% of variance. We included the latter 
category of SNPs to allow direct power comparisons across different simulation setups, as 
the 60 standardized effect SNPs always explain the same total amount of variance regardless 
of other simulation parameters. We further introduced environmental differences in ancestry 
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by including a phenotypic component aligned with the top principal component that 
explained an additional 1% of variance. (We note that principal component analysis is not 
part of BOLT-LMM; it is unnecessary to perform PCA when running mixed model 
association methods12.) We chose causal SNPs randomly from the first halves of 
chromosomes, leaving the second halves of chromosomes to contain only non-causal SNPs 
(Supplementary Note).
We computed χ2 association statistics using linear regression with 10 principal components 
(PCA)32, GCTA-LOCO12, BOLT-LMM-inf, and BOLT-LMM. We were unable to test 
FaST-LMM-Select15 on this data set because of its memory requirements (Fig. 1). For each 
method, we computed means of its χ2 statistics over standardized effect SNPs and compared 
these means across simulations involving different numbers of causal SNPs (Fig. 2a and 
Supplementary Table 2). We observed that BOLT-LMM achieved power gains by modeling 
non-infinitesimal architectures. For the sparsest genetic architecture (1,250 causal SNPs plus 
60 standardized effect SNPs), we observed a 25% increase in mean BOLT-LMM χ2 
statistics at standardized effect SNPs compared to GCTA-LOCO and BOLT-LMM-inf 
infinitesimal mixed model χ2 statistics. This metric is readily interpretable as corresponding 
to a 25% increase in effective sample size; for completeness, we also computed traditional 
power curves at two significance thresholds (Supplementary Fig. 3). The power gain of the 
Gaussian mixture model decreased with increasing numbers of causal SNPs (Fig. 2a). This 
behavior is expected because the advantage of the Gaussian mixture lies in its ability to 
more accurately model a small fraction of SNPs with larger effects amid a majority of SNPs 
with near-zero effects. Larger numbers of causal SNPs explaining a fixed proportion of 
variance result in smaller effect sizes per causal SNP, giving BOLT-LMM less opportunity 
for power gain. In contrast, all methods other than BOLT-LMM had performance 
independent of the number of causal SNPs, consistent with the fact that none of these 
methods model non-infinitesimal genetic architectures. GCTA-LOCO and BOLT-LMM-inf 
mean χ2 statistics at standardized effect SNPs were essentially identical and slightly 
exceeded PCA, consistent with theory12. We also tested EMMAX3 and GEMMA6, which 
are vulnerable to proximal contamination5,9,12; these methods suffered loss of power relative 
to PCA (Supplementary Fig. 4a), consistent with theory12.
To further explore the relationship between the magnitude of Gaussian mixture model power 
gain and other parameters of the data set, we also varied the proportion of variance 
explained by causal SNPs (Fig. 2b) and the number of individuals (Fig. 2c). We observed 
that the power boost of BOLT-LMM over infinitesimal mixed model analysis (GCTA-
LOCO, BOLT-LMM-inf) increased with each of these parameters. In further simulations 
using data sets of size N=30,000 and N=60,000 (Supplementary Note) and simulated 
phenotypes with Mcausal=250–15,000 causal SNPs explaining 15–35% of the variance, we 
observed that the effectiveness of the Gaussian mixture model is closely tied to hg2N/Mcausal 
(where hg2 is the heritability parameter estimated by BOLT-LMM; see Online Methods for 
interpretation); intuitively, this quantity measures the effective number of samples per causal 
SNP (Supplementary Fig. 5). These results are consistent with theory (Supplementary Note 
and Supplementary Table 2 of ref.12), which explains that even in the absence of 
confounding, mixed model analysis provides a power gain over marginal regression by 
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conditioning on the estimated effects of other SNPs when testing a candidate SNP9,12. As 
sample size increases, the power gain of both methods approaches an asymptote 
corresponding to an increase in effective sample size of 1/(1−hg2), but for sparse genetic 
architectures, the Gaussian mixture model approaches this asymptote much faster.
To verify that BOLT-LMM is correctly calibrated and robust to confounding, we also 
computed mean χ2 statistics across SNPs on the second halves of chromosomes, simulated 
to all have zero effect (“null SNPs”). Because our simulated phenotypes included an 
ancestry effect, linear regression without correcting for population stratification suffered 
35% inflation. In contrast, the BOLT-LMM and BOLT-LMM-inf statistics were both well-
calibrated (Supplementary Fig. 4b, Supplementary Table 3, and Supplementary Table 4). 
We further verified that Type I error was properly controlled (Online Methods and 
Supplementary Table 5) and that the distribution of statistics at null SNPs did not deviate 
noticeably from a 1 d.o.f. chi-squared distribution (Supplementary Fig. 6a,b). Genomic 
inflation factors33 for BOLT-LMM and BOLT-LMM-inf exceeded 1 in these simulations 
(Supplementary Fig. 6c,d), consistent with polygenicity of the simulated phenotype and use 
of a mixed model statistic that successfully avoids proximal contamination12,13. In contrast, 
EMMAX and GEMMA had deflated test statistics (Supplementary Fig. 4b).
To examine the tightness of the variational approximation used by BOLT-LMM for 
Bayesian model fitting and to enable comparison with FaST-LMM-Select, we ran a small-
scale simulation using the same setup as above but only one-third of the samples (N=5,211). 
We simulated genetic architectures with 1,250 causal SNPs explaining 70% of phenotypic 
variance (and 60 additional standardized effect SNPs explaining 2% of variance and 
ancestry explaining 1%, as before). We ran PCA, BOLT-LMM-inf, BOLT-LMM, FaST-
LMM-Select, and a modified version of BOLT-LMM in which we replaced the variational 
iteration of Step 2b with a Markov chain Monte Carlo (MCMC) Gibbs sampler. In the limit 
of infinite sampling iterations, MCMC would produce exact versions of the posterior 
approximations computed by BOLT-LMM. In these simulations, the variational iteration 
(i.e., standard BOLT-LMM) achieved statistically identical results to MCMC 
(Supplementary Table 6a), supporting the choice of variational Bayes for BOLT-LMM. We 
also observed that while BOLT-LMM-inf achieved a power gain over PCA and BOLT-
LMM achieved a further power gain over BOLT-LMM-inf (consistent with previous 
simulations), FaST-LMM-Select achieved lower power than BOLT-LMM-inf and BOLT-
LMM (Supplementary Table 6a). Upon repeating this experiment with the number of causal 
SNPs reduced to 500, we observed that FaST-LMM-Select achieved a power gain in 
between BOLT-LMM-inf and BOLT-LMM (Supplementary Table 6b). Finally, we 
observed that the LD Score calibration approach used by BOLT-LMM also worked well 
when applied to FaST-LMM-Select, validating this calibration approach (Supplementary 
Table 6).
Lastly, we investigated the similarity between the BOLT-LMM-inf mixed model statistic 
and existing methods at the individual SNP level. Despite its use of an infinitesimal model, 
the BOLT-LMM-inf statistic is not identical to any existing mixed model statistic because it 
is an approximate test statistic and avoids proximal contamination (Online Methods and 
Table 1). Nonetheless, we observed that BOLT-LMM-inf statistics very nearly match 
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GCTA-LOCO statistics (which use the standard prospective model), with R2>0.999 
(Supplementary Table 7 and Supplementary Fig. 7).
Application of BOLT-LMM to WGHS phenotypes
To assess the efficacy of Gaussian mixture model analysis for increasing power on real 
phenotypes, we analyzed nine phenotypes in the Women’s Genome Health Study (N=23,294 
samples, M=324,488 SNPs after QC) (Online Methods). These phenotypes consisted of five 
lipid phenotypes, height, body mass index, and two blood pressure phenotypes; we chose to 
analyze these phenotypes because of the availability of large-scale GWAS results.
We compared the power of three association tests: linear regression with 10 principal 
components (PCA)32, infinitesimal mixed model analysis with BOLT-LMM-inf, and 
Gaussian mixture modeling with BOLT-LMM. Because of memory constraints (Fig. 1), we 
were unable to run GCTA-LOCO12, FaST-LMM5, or FaST-LMM-Select15, which are the 
only previous methods that avoid proximal contamination (Table 1); however, GCTA-
LOCO and BOLT-LMM-inf statistics are near-identical (Supplementary Table 7 and 
Supplementary Fig. 7). To compare power among these methods, we computed two roughly 
equivalent metrics: mean χ2 statistics at known associated loci, a direct but somewhat noisy 
approach due to having only 19–180 loci for each trait (Supplementary Table 8), and out-of-
sample prediction R2 (measured in cross-validation) using all SNPs for the mixed model 
methods and using only PCs for linear regression. For mixed model analysis, the latter 
metric estimates the ability of the mixed model to condition on effects of other SNPs when 
testing a candidate SNP, which drives its power (Online Methods)12,34.
BOLT-LMM achieved higher power than PCA for all traits studied (Fig. 3 and 
Supplementary Table 9). Most of the increase was due to gains over infinitesimal mixed 
model analysis, with the magnitude of this power gain increasing with inferred concentration 
of genetic effects at few loci (Supplementary Table 10). Standard errors of the direct method 
of assessing improvement (mean χ2 at known loci) were somewhat high (0.6–2.2%; Fig. 3a 
and Supplementary Table 9), so the improvement was statistically significant (p<0.05) for 
only 6 of 9 traits. According to the prediction R2 metric, improvements were statistically 
significant for all traits (p<0.0002) (Fig. 3b and Supplementary Table 9). The largest gains 
were achieved for lipid traits; for ApoB, a lipoprotein closely related to LDL cholesterol, 
BOLT-LMM analysis achieved a 10% increase in mean χ2 statistics versus PCA and a 9% 
increase versus infinitesimal mixed model analysis at known loci. To verify that these 
increases were not merely driven by a few loci with the largest effects, we also computed 
flat averages across loci of improvements in χ2 statistics (restricting to loci replicating in 
WGHS with at least nominal p<0.05 significance to reduce statistical noise) and obtained 
consistent results (Supplementary Table 8). Simulations show that these improvements will 
increase with sample size (Fig. 2c and Supplementary Fig. 5).
We also observed that infinitesimal mixed model analysis achieved statistically significant 
power gains over PCA, with the magnitude of the power gains increasing with the 
heritability parameter hg2 (Fig. 3 and Supplementary Table 9). For height (hg2=0.47 in 
WGHS), the moderately large sample size of WGHS (N=23,294) was enough to obtain a 6% 
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increase in BOLT-LMM-inf χ2 statistics versus PCA, consistent with theory12,34. Again, 
larger sample sizes will enable further gains12,34.
To verify that BOLT-LMM successfully corrected for confounding from population 
structure, we computed mean χ2 statistics across all typed SNPs and genomic inflation 
factors for the three methods compared above as well as uncorrected marginal linear 
regression. We observed that PCA, BOLT-LMM-inf, and BOLT-LMM statistics were 
consistently calibrated, while uncorrected linear regression statistics were inflated, 
especially for height (Supplementary Table 11). We further verified that genetic variation at 
the lactase gene had a false-positive genome-wide significant association with height using 
uncorrected marginal regression35 which disappeared when using PCA, BOLT-LMM-inf, 
and BOLT-LMM (Supplementary Table 12).
Discussion
We have described a new algorithm for fast Bayesian mixed model association, BOLT-
LMM, and demonstrated that its running time scales only with ≈MN1.5 and its memory 
usage is only ≈MN/4 bytes, resulting in orders-of-magnitude improvements in 
computational efficiency over existing methods for large data sets. We have further shown 
in simulations and analyses of WGHS phenotypes that the Gaussian mixture modeling 
capability of BOLT-LMM enables increased association power over standard mixed model 
analysis while controlling false positives. Among WGHS lipid traits, we observed power 
increases equivalent to increases in effective sample size of up to 10% over PCA and 9% 
over standard mixed model analysis.
BOLT-LMM is an advance for two main reasons. First, as sample sizes continue to increase, 
mixed model analysis is simultaneously becoming more important—in order to correct for 
population structure and cryptic relatedness in very large data sets—yet less practical with 
existing methods, all of which have ≥O(MN2) time complexity (for M>N) and high memory 
requirements. The algorithmic innovations of BOLT-LMM overcome this computational 
barrier (Fig. 1). (Our implementation uses ≈MN/4 bytes of memory, which is already much 
less in practice than existing methods. In theory, existing algorithms have a memory 
complexity of O(N2), while BOLT-LMM’s memory complexity could be reduced to O(M
+N) by iteration on data.) Second, the ability of BOLT-LMM to better model non-
infinitesimal genetic architectures enables a power gain relative to standard mixed model 
analysis. Recent methodological progress in this direction includes the multi-locus mixed 
model (MLMM)7, which identifies and conditions out large-effect loci as fixed effects, and 
FaST-LMM-Select and related methods9,11,15,16,36, which adopt a sparse regression 
framework that restricts the mixed model to a subset of markers. However, these methods all 
face the same O(MN2) computational hurdle as standard mixed model analysis.
Bayesian methods have previously been developed that apply non-infinitesimal models to 
improve the accuracy of genetic risk prediction. These methods extend in principle to 
association testing, although the Bayes factors and posterior inclusion probabilities that are 
naturally produced by Bayesian analysis do not directly translate to customary GWAS 
frequentist test statistics37. The variational Bayes spike regression (vBsr) method38 is a 
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recent step toward addressing this issue, proposing a z-statistic heuristically calibrated by 
assuming that the vast majority of variants are unassociated (as in genomic control33), but 
such a technique is prone to deflation when large sample sizes cause inflation due to 
polygenicity13,24. BOLT-LMM sidesteps this difficulty via its hybrid approach of leaving 
each chromosome out in turn, fitting a Bayesian model on the remaining SNPs, and then 
applying a retrospective hypothesis test for association of left-out SNPs with the residual 
phenotype. In contrast to modeling all SNPs simultaneously and assessing evidence for 
association using Bayesian posterior inference37, our approach generalizes existing mixed 
model methods that are widely used, and we believe its ability to harness the power of 
Bayesian analysis while still computing frequentist statistics will be useful to GWAS 
practitioners. Additionally, such a hybrid approach lends itself readily to efficiently testing 
millions of imputed SNP dosages for association while including only typed SNPs in the 
mixed model, which we recommend to limit computational costs.
While BOLT-LMM improves upon existing mixed model association methods in both speed 
and power, BOLT-LMM still has limitations. First, the power gain that BOLT-LMM offers 
over existing methods via its more flexible prior on SNP effect sizes is contingent on the 
true genetic architecture being sufficiently non-infinitesimal and the sample size being 
sufficiently large (Supplementary Fig. 5). Second, BOLT-LMM, like existing mixed model 
methods, is susceptible to loss of power when used to analyze large ascertained case-control 
data sets in diseases of low prevalence12. We recommend BOLT-LMM for randomly 
ascertained quantitative traits, ascertained case-control studies of diseases with prevalence 
≥5% (Supplementary Table 13)—e.g., type 2 diabetes, heart disease, common cancers, 
hypertension, asthma—and studies of rarer diseases in large, non-ascertained population 
cohorts39,40. For large ascertained case-control studies of rarer diseases, we are developing a 
method of modeling ascertainment using posterior mean liabilities (LTMLM); applying the 
techniques of BOLT-LMM to these posterior mean liabilities is an avenue for future 
research. Third, while mixed model analysis is effective in correcting for many forms of 
confounding, performing careful data quality control remains critical to avoiding false 
positives. Fourth, our work does not attempt to estimate the extent to which the heritability 
parameter estimated by BOLT-LMM (denoted hg2) may be influenced by population 
structure or relatedness, nor does it conduct or evaluate genetic prediction in external 
validation samples from an independent cohort34. Fifth, we have not studied the 
performance of mixed model methods in data sets dominated by family structure23. Sixth, 
the running time of BOLT-LMM scales with the number of phenotypes analyzed; for data 
sets with a very large number of phenotypes (P), the GRAMMAR-Gamma method10, which 
has running time O(MN2+MNP) (reviewed in ref.12) may be faster. Seventh, we have only 
tested BOLT-LMM in human data sets, which have very different patterns of linkage 
disequilibrium and genetic architectures from plant and animal data. In particular, given that 
some approximations we make may be violated in non-human data sets (e.g., treating the 
denominator of the prospective test statistic as near-constant10), we are unsure whether the 
BOLT-LMM statistic is valid in these scenarios. Similarly, these assumptions should be 
viewed with caution when testing very rare variants. Finally, we have developed fast mixed 
model analysis for a mixed model with one random genetic effect; extending the algorithm 
to model multiple variance components41 is a direction for future work.
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Online Methods
Standard mixed model association methods
Standard methods employ a model
(1)
where y is the phenotype, xtest is the candidate SNP being tested, g is the genetic effect, and 
e is the environmental effect. We assume for now that all have been mean-centered and 
there are no covariates; we treat covariates by projecting them out from both genotypes and 
phenotypes, which is equivalent to including them as fixed effects (Supplementary Note). 
The genetic and environmental effects are modeled as random effects, while the candidate 
SNP is modeled as a fixed effect with coefficient βtest, and the goal is to test the null 
hypothesis βtest=0. Under the standard infinitesimal model, the genetic effect is modeled as
(2)
where XGRM is an N×MGRM matrix, each column of which contains normalized genotypes 
corresponding to a SNP included in the model, and βGRM is an MGRM-vector of random 
SNP effect sizes all drawn from the same normal distribution, so that g has a multivariate 
normal distribution with covariance Cov(g) ∝ XGRMXGRM'. Note that in order to avoid 
proximal contamination5,9,12, the MGRM SNPs used in XGRM should vary depending on 
which SNP xtest is being tested: the candidate SNP xtest (and SNPs in linkage disequilibrium 
with it) should be excluded from XGRM to avoid modeling its effect twice. BOLT-LMM 
adopts a leave-one-chromosome-out (LOCO) scheme5,12 in which XGRM leaves out SNPs 
on the same chromosome as xtest.
The matrix XGRMXGRM'/MGRM is conventionally called the genetic relationship matrix 
(GRM) or empirical kinship matrix K, and we write
(3)
where σg2 is a variance parameter. Environmental effects are assumed i.i.d. normal, so e is 
also multivariate normal with
(4)
where I denotes the N×N identity matrix and σe2 is another variance parameter.
In practice, the variance parameters σg2 and σe2 are unknown. Several existing 
methods3,10,12 therefore take a two-step approach to computing association statistics: first 
estimate the variance parameters (with the SNP xtest removed from the model) using 
restricted maximum likelihood (REML), and then compute the prospective chi-squared (1 
d.o.f.) test statistic (as previously proposed in family-based tests42)
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(5)
where
(6)
setting the variance parameters σg2 and σe2 to their estimates under the null hypothesis 
βtest=0. Within a LOCO scheme, the test statistic becomes
(7)
where we have written VLOCO for V to explicitly indicate that the chromosome containing 
xtest is left out of the GRM.
Recent computational advances have also enabled computation of exact likelihood ratio test 
statistics that model the variance parameters while testing the candidate SNP5,6. While exact 
statistics are more accurate in situations with very large-effect SNPs, approximate methods 
produce near-identical results in typical human genetics scenarios3,10,12.
BOLT-LMM-inf mixed model statistic
The BOLT-LMM-inf infinitesimal mixed model statistic is slightly different:
(8)
where cinf is a constant calibration factor estimated as
(9)
so that
(10)
In practice, for computational efficiency, we take means over 30 pseudorandom SNPs not 
significantly associated with the phenotype (χ2<5 estimated with the GRAMMAR 
statistic43). We have observed empirically that 30 random SNPs are enough to estimate the 
calibration factor to within 1% (Supplementary Table 14).
We can view the BOLT-LMM-inf statistic either as an approximation of the standard 
prospective statistic (which treats phenotypes as random) or as a retrospective statistic 
(which treats genotypes as random and builds a null model on SNPs). The first perspective 
is motivated by the observation that in human genetics applications, the denominator of the 
prospective statistic in equation (5), xtest'V−1xtest, is nearly independent of the SNP xtest 
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being tested10. From this perspective, BOLT-LMM-inf is similar to GRAMMAR-Gamma10, 
with two key differences: (1) BOLT-LMM-inf is computed via much faster algorithms 
(described below) for performing initial variance parameter estimation and estimating the 
calibration constant, and (2) BOLT-LMM-inf avoids proximal contamination via LOCO 
analysis. Alternatively, we can also view BOLT-LMM-inf as a retrospective quasi-
likelihood score test similar to TSCORE–R (ref.44) and MASTOR23 (Supplementary Note).
BOLT-LMM Gaussian mixture model association statistic
We now generalize BOLT-LMM-inf by observing that the vector VLOCO−1y appearing in 
equation (8) is a scalar multiple of the residual phenotype vector σe2VLOCO−1y from best 
linear unbiased prediction (BLUP). Thus, the χ2BOLT-LMM-inf statistic is equivalent to 
computing (and then calibrating) squared correlations between SNPs xtest and BLUP 
residuals. The power of mixed model association is driven by the fact that SNPs xtest are 
tested against these “de-noised” residual phenotypes from which other SNP effects 
estimated by the mixed model have been conditioned out9,12.
We may generalize this approach by defining
(11)
where yresid-LOCO denotes a generalized residual phenotype vector obtained after fitting a 
Gaussian mixture extension of the standard LMM (using SNPs not on the same chromosome 
as xtest) and c denotes a calibration factor, estimated so that the LD Score regression 
intercept24 of χ2BOLT-LMM matches that of the (properly calibrated) χ2BOLT-LMM-inf statistic. 
Under the infinitesimal model, yresid-LOCO is proportional to VLOCO−1y, so χ2BOLT-LMM 
reduces to χ2BOLT-LMM-inf. The general χ2BOLT-LMM statistic can still be interpreted as a 
retrospective quasi-likelihood score test and is thus asymptotically chi-squared distributed.
To define the Gaussian mixture LMM extension, it is helpful to first frame the standard 
LMM in a Bayesian formulation. The null model of BOLT-LMM-inf is
(12)
where SNP effects βm (m indexing SNPs not on the left-out chromosome) are independently 
drawn from the Gaussian prior distribution
(13)
and environmental effects en (n indexing samples) are independently drawn from en ~ N(0, 
σe2). Performing best linear unbiased prediction amounts to computing the posterior mean of 
the genetic effect XLOCOβLOCO.
To generalize this model to non-infinitesimal genetic architectures, we replace the Gaussian 
prior on SNP effect sizes with a more general distribution; this approach has been 
extensively applied by the “Bayesian alphabet” of genomic prediction methods in the animal 
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breeding literature17–19. In BOLT-LMM, we use a spike-and-slab mixture of two 
Gaussians19 as the prior:
(14)
This mixture more flexibly models the heavier-tailed distributions of genetic effects of 
typical (non-infinitesimal) phenotypes. Explicitly, if p≪1 and σβ,12 ≫ σβ,22, the first 
component of the mixture is a “slab” that models the existence of a small number of 
relatively large-effect loci, while the second component is a “spike” that models the 
assumption that most SNPs have near-zero—but not exactly zero—effect on the phenotype. 
(Note, however, that all SNPs are assigned the same mixture prior; i.e., SNPs are not 
individually allocated to one or the other component.) It is important that the spike 
component have nonzero variance so as to capture genome-wide effects on phenotype such 
as ancestry or relatedness; then, when testing SNPs for association, these genome-wide 
effects are conditioned out from residual phenotypes, protecting against confounding. The 
prior could in principle be further generalized; we chose to use a mixture of two Gaussians 
to keep the model fairly simple and because Gaussian distributions produce convenient 
analytical formulas during model-fitting.
Under this generalized model, posterior means no longer correspond to BLUP, but we can 
still approximately fit the Bayesian model (once per left-out chromosome) and obtain 
residuals
(15)
where βLOCO are estimated posterior mean effect sizes. Plugging these residuals into 
equation (11) gives the BOLT-LMM Gaussian mixture model association test statistic.
Fast iterative algorithm
The BOLT-LMM software performs a four-step computation for mixed model association 
analysis, stopping after the first two steps when specialized to the infinitesimal model. We 
outline the algorithm here and provide full details and pseudocode in the Supplementary 
Note.
Step 1a: Estimate variance parameters
A key feature of BOLT-LMM is estimation of variance parameters σg2 and σe2 using only 
linear-time iterations without building or decomposing any covariance matrices. We use a 
Monte Carlo REML approach26,27 that eliminates all O(MN2) and O(N3)-time matrix 
computations, requiring only the solution of linear systems of mixed model equations. We 
solve the mixed model equations using conjugate gradient iteration, which requires only 
O(MN)-time matrix-vector products28,29 (Supplementary Note).
Step 1b: Compute and calibrate BOLT-LMM-inf statistics
Having variance parameter estimates from Step 1a, it is straightforward to compute (for each 
LOCO rep) the quantity VLOCO−1y in the numerator of the BOLT-LMM-inf statistic, 
equation (8), using conjugate gradient iteration as above. Completing the computation of the 
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numerator of χ2BOLT-LMM-inf then just amounts to calculating one dot product per SNP xtest, 
which requires only O(MN) additional cost across all SNPs. Moreover, this computation can 
easily be performed for additional SNPs not included in the mixed model but at which 
association statistics are desired; BOLT-LMM handles imputed “dosage” data in this way. 
To compute the calibration constant cinf in equation (9), BOLT-LMM rapidly computes the 
prospective statistic χ2LMM-LOCO from equation (7) at 30 random SNPs by applying 
conjugate gradient iteration to compute VLOCO−1xtest for each of the 30 selected SNPs xtest. 
Finally, in addition to computing χ2 association statistics, BOLT-LMM also computes effect 
size estimates for all SNPs tested (Supplementary Note).
There is a slight mismatch between the variance parameters estimated in Step 1a, which 
BOLT-LMM computes once using all SNPs—not leaving any chromosomes out—and the 
theoretically optimal parameter estimates that would be obtained by refitting once per left-
out chromosome. However, we have observed in simulations that slight mis-specification of 
the variance parameters has a negligible impact (<0.5%) on the calibration of the BOLT-
LMM-inf and BOLT-LMM statistics (Supplementary Table 4). Because very slight 
miscalibration is not a concern for confounding from population stratification at highly 
differentiated markers (Supplementary Table 12) and has little impact on Type I error 
(Supplementary Table 5), the BOLT-LMM software does not by default refit variance 
parameters for each LOCO rep. If extremely precise calibration is desired, we provide a 
runtime option to refit variance parameters for each LOCO rep, at the cost of a factor of 2–3 
in running time. We believe that LOCO strikes a good balance in terms of achieving ≈95% 
of the potential power gain (by jointly fitting ≈95% of markers that are not in LD with the 
candidate marker) while keeping run time down12, but we also provide a runtime option to 
partition the genome more finely (e.g., into 100 segments rather than 22), again at the cost of 
a factor of 2–3 in running time.
Step 2a: Estimate Gaussian mixture prior parameters
The first step of BOLT-LMM Gaussian mixture model association analyis is to estimate 
parameters of the generalized prior on SNP effect sizes. As written in equation (14), this 
mixture has three parameters: σβ,12 and σβ,22, the variances of the two Gaussians, and p, the 
probability of drawing from the first Gaussian. To reduce the complexity of parameter 
estimation, we constrain the total variance of the mixture to equal the variance σg2/M 
estimated under the infinitesimal model in Step 1a:
(16)
We reparameterize the remaining two degrees of freedom using the parameters p and f2, 
where f2 denotes the proportion of the total mixture variance within the second Gaussian 
(the “spike” component that models small genome-wide effects):
(17)
Because the model fit is insensitive to the precise values of the mixture parameters, we test a 
discrete set of model parameter combinations: f2∈{0.5,0.3,0.1}, p∈
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{0.5,0.2.0.1,0.05,0.02,0.01}. Note that f2=0.5, p=0.5 corresponds to the infinitesimal model: 
when f2=1−p, the two Gaussians are identical and the mixture is degenerate. We bound f2 
from below to ensure that at least a small amount (10%) of the mixture variance is assigned 
to the spike component, protecting against confounding from genome-wide effects. We 
bound p from below to prevent the model from trying to fit too strongly to a few SNPs, 
which makes model-fitting computationally difficult and also increases susceptibility to 
confounding. BOLT-LMM performs model selection among the 18 possible parameter pairs 
(f2, p) by performing cross-validation to optimize mean-squared prediction R2.
BOLT-LMM uses a variational approximation to fit Bayesian linear regressions with 
Gaussian mixture priors. Approximation methods are necessary for Bayesian inference in 
this setting because exact posterior means involve intractable integrals. We apply a fully 
factored variational approximation21,22,38 that repeatedly loops through the SNPs, updating 
the estimated effect size of each SNP with its posterior mean conditional on current 
estimates of all other SNP effects. This iteration has also previously been termed “iterative 
conditional expectation (ICE)”20. The variational Bayes framework puts this iteration on a 
sound theoretical footing as an optimization of an approximate log likelihood function; the 
iteration monotonically increases this function and is guaranteed to converge45. In fact, we 
show that the optimization can be reformulated as cyclic coordinate descent applied to a 
penalized regression problem arising from Bayesian linear regression using a transformed 
prior (Supplementary Note). The approximate log likelihood also serves as a convenient 
convergence criterion: BOLT-LMM stops the iteration when the increase in approximate log 
likelihood over one full update cycle drops below 0.01.
While the core variational iteration that BOLT-LMM uses is identical to previous 
methods20–22,38 up to the choice of SNP effect size prior, BOLT-LMM uses cross-validation 
to estimate hyperparameters15 rather than doing so within the variational iteration22,38 or 
based on variational approximate log likelihoods21. We found this approach to be more 
robust to slackness of the variational approximation caused by linkage disequilibrium.
Step 2b: Compute and calibrate BOLT-LMM Gaussian mixture model statistics
After inferring parameters of the mixture prior in Step 2a, BOLT-LMM uses the same 
variational iteration to estimate posterior mean residuals yresid-LOCO (independently for each 
left-out chromosome). The numerators of the BOLT-LMM Gaussian mixture model statistic 
from equation (11) are then easily obtained as dot products with test SNPs, leaving only the 
constant calibration factor c in the denominator to be calculated. Unlike the case of the 
infinitesimal model, here we do not have a prospective statistic to calibrate against, so we 
instead apply LD Score regression24 (Supplementary Note). In practice, the calibration 
factor is usually quite close to 1 (e.g., 1.00 to two decimal places for all WGHS traits; see 
Supplementary Table 15).
WGHS data set
The Women’s Genome Health Study (WGHS) is a prospective cohort of initially healthy, 
female North American health care professionals. We analyzed 23,294 individuals with self-
Loh et al. Page 15
Nat Genet. Author manuscript; available in PMC 2015 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
reported European ancestry with genotyping at 324,488 SNPs after QC (Supplementary 
Note).
Interpretation of heritability parameter
The heritability parameter (denoted hg2) estimated by BOLT-LMM may in general include 
some contribution from cryptic relatedness or population structure46, and thus may not 
strictly correspond to the heritability explained by genotyped SNPs47. Ref.3 refers to this 
parameter as “pseudo-heritability” for this reason. Because the WGHS samples that we 
primarily analyze here do not contain substantial relatedness or population structure, we 
have simply used the notation hg2 to avoid complicating the discussion.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Computational performance of mixed model association methods
Log-log plots of (a) run time and (b) memory as a function of sample size (N). Slopes of the 
curves correspond to exponents of power-law scaling with N. Benchmarking was performed 
on simulated data sets in which each sample was generated as a mosaic of genotype data 
from 2 random “parents” from the WTCCC2 data set (N=15,633, M=360K) and phenotypes 
were simulated with Mcausal=5,000 SNPs explaining h2causal=0.2 of phenotypic variance. 
Reported run times are medians of five identical runs using one core of a 2.27 GHz Intel 
Xeon L5640 processor. We caution that running time comparisons may vary by a small 
constant factor as a function of computing environment. FaST-LMM-Select (resp. GCTA-
LOCO, EMMAX) memory usage exceeded the 96GB available at N=15K (resp. 30K, 60K). 
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GEMMA encountered a runtime error (segmentation fault) at N=30K. Software versions: 
FaST-LMM-Select, v2.07; GCTA-LOCO, v1.24; EMMAX, v20120210; GEMMA, v0.94. 
Numerical data are provided in Supplementary Table 1.
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Figure 2. BOLT-LMM increases power to detect associations in simulations
Mean χ2 at standardized effect SNPs as a function of (a) number of causal SNPs, (b) 
proportion of variance explained by causal SNPs, (c) number of samples. Simulations used 
real genotypes from the WTCCC2 data set (N=15,633, M=360K) and simulated phenotypes 
with the specified number of causal SNPs explaining the specified proportion of phenotypic 
variance and 60 more standardized effect SNPs explaining an additional 2% of the variance. 
Error bars, s.e.m., 100 simulations. We verified on the first 5 simulations that the BOLT-
LMM-inf and GCTA-LOCO statistics are nearly identical (Supplementary Table 7). 
Numerical data are provided in Supplementary Table 2.
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Figure 3. BOLT-LMM increases power to detect associations for WGHS phenotypes
We compare power (measured using two roughly equivalent metrics) of linear regression 
using 10 principal components, standard (infinitesimal) mixed model analysis, and BOLT-
LMM Gaussian mixture model analysis. (a) Percent increases in χ2 statistics across known 
loci using mixed model methods vs. PCA: ratios of sums of χ2 statistics over typed SNPs in 
highest LD with published associated SNPs. (b) Prediction R2 values from 5-fold cross-
validation: each fold was left out in turn and predictions were computed by fitting all SNP 
effects simultaneously (for mixed model methods) or estimating covariate effects (for PCA) 
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using the training folds. (Note that BOLT-LMM-inf is equivalent to BLUP prediction here.) 
We show PCA in (b) because the small amount of variance that the PCs explain (due to 
population stratification) provides a baseline that allows translating prediction R2 to the 
power gain of mixed model association vs. regression with PC covariates. That is, the 
correspondence between association power and prediction accuracy is such that the red bars 
in (a) roughly correspond to differences between red and black bars in (b), and analogously 
for blue bars (Online Methods). Error bars, jackknife s.e. over (a) known loci 
(Supplementary Table 8); (b) 5 cross-validation folds. Numerical data are provided in 
Supplementary Table 9.
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Table 1
Comparison of fast mixed model association methods that model all SNPs.
Methoda Requires O(MN2) time Avoids proximal
contamination
Models
non-infinitesimal
genetic architecture
EMMAX [3] X
FaST-LMM [5] Xb X
FaST-LMM-Select [9, 11, 15] Xb X Xc
GEMMA [6] X
GRAMMAR-Gamma [10] Xd
GCTA-LOCO [12] X X
BOLT-LMM X X
a
For methods that have been updated over multiple publications, we cite and list characteristics of the latest published version.
b
If M<N, FaST-LMM and FaST-LMM-Select can complete in O(M2N) time.
c
FaST-LMM-Select models non-infinitesimal genetic architectures by restricting the mixed model to a subset of SNPs; a caveat of this approach is 
that it may incur susceptibility to confounding from stratification12.
dGRAMMAR-Gamma requires O(MN2) time for only the initial computation of the genetic relationship matrix but not for computing association 
test statistics. For a detailed breakdown of computational complexity per algorithmic step, see Table 1 of ref.12.
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